Garrett Powell Jr., MD1, Paige Mosteller, BS2, Don Donnelly, BS2, and Dave Primm, MA, ELS2. (1) neurosurgeon in private practice, Nashville, TN, USA, (2) Advanced Neuromodulation Systems, Plano, TX, USA
Introduction Paddle leads with three parallel electrode arrays
(i.e., tripolar leads) are increasingly used for spinal cord stimulation.
Preliminary data has suggested that tripolar leads can provide broad
paresthesia coverage to patients with concurrent low back and low extremity
pain.1 In this poster, we present the initial outcomes of chronic
pain patients who were treated with spinal cord stimulation using an
anatomically shaped tripolar lead. Methods
Data was collected retrospectively
on 8 patients suffering from refractory low back and leg pain who had been
implanted with tripolar leads. The data included information on pain relief,
paresthesia coverage, and stimulation programming. The tripolar lead had a
middle array of six electrodes flanked by two outside arrays of five electrodes
each (Fig. 1). The electrodes could be individually controlled to direct the
stimulation over the dorsal columns. In cross-section, the lead was contoured
to help it conform to the shape of the dura. Results All patients had been
diagnosed with failed back surgery syndrome and had pain in the low back,
buttocks, and/or legs (Table 1). The majority of patients had axial back pain
that extended to the L4 vertebral level. At an average of (info pending) months
post-implantation, the patients reported substantial declines in pain (Fig. 2).
All but one patient had complete coverage of their pain topography. Programming
parameters for the patients varied, as did the location of their electrode combinations
on the lead (Fig. 3). Conclusion In this preliminary survey, tripolar leads provided
broad paresthesia coverage to patients with low back and lower extremity pain,
with pain relief extending as high as the L4 dermatomes.
References: 1. Hale G, Calava J. Using tripolar spinal cord
stimulation leads to treat concurrent low back and leg pain: preliminary
results. Poster presented at: Annual Meeting of the North American
Neuromodulation Society; Nov. 10-12, 2005; Washington, DC.